v3.25.2
Statements of Changes In Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 868 [1] $ 22,762,922 $ (15,071,415) $ 7,692,375
Balance (in Shares) at Dec. 31, 2023 [1] 868,184      
Issuance of common shares from exercise of pre-funded warrants $ 199 [1] 99 298
Issuance of common shares from exercise of pre-funded warrants (in Shares) [1] 199,047      
Equity-based compensation - options 355,851 355,851
Net loss (4,056,270) (4,056,270)
Balance at Jun. 30, 2024 $ 1,067 [1] 23,118,872 [1] (19,127,685) 3,992,254
Balance (in Shares) at Jun. 30, 2024 [1] 1,067,231      
Balance at Mar. 31, 2024 $ 1,067 [1] 22,925,752 [1] (16,734,703) 6,192,116
Balance (in Shares) at Mar. 31, 2024 [1] 1,067,231      
Equity-based compensation - options 193,120 [1] 193,120
Net loss (2,392,982) (2,392,982)
Balance at Jun. 30, 2024 $ 1,067 [1] 23,118,872 [1] (19,127,685) 3,992,254
Balance (in Shares) at Jun. 30, 2024 [1] 1,067,231      
Balance at Dec. 31, 2024 $ 1,782 33,160,576 (25,722,783) 7,439,575
Balance (in Shares) at Dec. 31, 2024 1,782,486      
Equity-based compensation - options 1,008,034 1,008,034
Issuance of common stock for consulting services $ 35 133,340 133,375
Issuance of common stock for consulting services (in Shares) 35,000      
Proceeds from sale of common stock, net issuance costs $ 186 3,198,413 3,198,599
Proceeds from sale of common stock, net issuance costs (in Shares) 186,294      
Exercise of stock options $ 3 31,994 $ 31,997
Exercise of stock options (in Shares) 3,333     3,333
Net loss (7,512,667) $ (7,512,667)
Balance at Jun. 30, 2025 $ 2,006 37,532,357 (33,235,450) 4,298,913
Balance (in Shares) at Jun. 30, 2025 2,007,113      
Balance at Mar. 31, 2025 $ 1,909 35,679,350 (29,568,163) 6,113,096
Balance (in Shares) at Mar. 31, 2025 1,909,732      
Equity-based compensation - options   489,144 489,144
Issuance of common stock for consulting services $ 10 103,490 103,500
Issuance of common stock for consulting services (in Shares) 10,000      
Proceeds from sale of common stock, net issuance costs $ 84 1,228,379 1,228,463
Proceeds from sale of common stock, net issuance costs (in Shares) 84,048      
Exercise of stock options $ 3 31,994 31,997
Exercise of stock options (in Shares) 3,333      
Net loss (3,667,287) (3,667,287)
Balance at Jun. 30, 2025 $ 2,006 $ 37,532,357 $ (33,235,450) $ 4,298,913
Balance (in Shares) at Jun. 30, 2025 2,007,113      
[1] All share and per share information has been retroactively adjusted to reflect the 1-for-15 reverse stock split effected on August 20, 2024. See Note 6, Stockholders’ Equity for additional information.